# A Study of Gaboxadol in Primary Insomnia

> **NCT00209846** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 320 (—)

## Conditions studied

- Primary Insomnia

## Interventions

- **DRUG:** Gaboxadol

## Key facts

- **NCT ID:** NCT00209846
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 320 (—)
- **Last updated:** 2007-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209846, "A Study of Gaboxadol in Primary Insomnia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00209846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*